RaDIANT Health Systems Intervention
Recruiting · NCT07033117 · Interventional (participants receive a specific treatment) · Lead sponsor: Indiana University
View the official record on ClinicalTrials.gov →Interventions studied
Audit and Tracking of Patient Contact Attempts Prior to Referral ClosureDialysis Facility Awareness CampaignPatient Contact via Preferred MethodPerformance Feedback Reports on Referral and Evaluation ClosuresPhone Call to Dialysis Facility During the Patient's Dialysis SessionPhone Call to ProviderTransplant Referral Communication Platforms or Email to Communicate Patient Status and No-Show
What this trial is about
The overarching goal of the proposed study is to determine whether the addition of structural interventions at the health system level targeting upstream barriers in the transplant process will improve access to transplant evaluation start.
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Five large transplant centers (Emory Transplant Center and Piedmont Transplant Center in Atlanta, GA; Medical University of SC; Duke University in Durham, NC; and Indiana University in Indianapolis, IN) \~800 referring dialysis center referring to these transplant centers
Exclusion criteria
- Individuals referred, initiating evaluation, and waitlisted at non-participating start centers
Where it is running
5 locations listed across 4 US states.
- Piedmont Transplant Institute - Atlanta, Georgia, United States
- Emory Transplant Center - Atlanta, Georgia, United States
- IU Health Transplant - Indianapolis - Indianapolis, Indiana, United States
- Duke Transplant Center - Durham, North Carolina, United States
- MUSC Mid-Carolinas Transplant Center - Lancaster, South Carolina, United States